PDF Download

Oct 18 (Wed) 11:00-12:50
Registration
All
Oct 18 (Wed) 13:00-14:30
RAPID Consensus
Danish Model for ISLS Consensus on Recommendations for RAPID Liver Transplant
Main Room
13:00-13:10
Introduction of ISLS and its research program
Deniz Balci (Turkiye)
13:10-13:20
RAPID the birth of a new concept: how it happened
Pal-Dag Line (Norway)
13:20-13:35
Systematic review of RAPID: where do we stand in 2023?
Dimitri Raptis (United Kingdom)
13:35-13:50
Why RAPID? Why a Consensus? Why Now?
Massimo Malago (United Kingdom)
13:50-14:00
Welcome form the President of the Congress
Henrik Petrowsky (Switzerland)
14:00-14:30
Agreement on the nomenclature of two stage liver transplant procedures: What qualifies as RAPID? • Similarities & differences of the different techniques
Silvio Nadalin (Germany)
Oct 18 (Wed) 14:30-14:50
Coffee Break
All
Oct 18 (Wed) 14:50-16:20
RAPID Consensus
Danish Model for ISLS Consensus on Recommendations for RAPID Liver Transplant
Main Room
14:50-15:20
Which preoperative assessment modalities best identify patients who are suitable for RAPID in the setting of portal vs. no portal hypertension? • What are the indications for RAPID?
Olivier Scatton (France)
15:20-15:50
What are the criteria for graft selection for the RAPID procedur ompatible with improved outcomes of the recipient? • What is the lower limit of graft to recipient weight ratio (GRWR) after RAPID?
Prashant Bhangui (India)
15:50-16:20
Which surgical technique is optimal for the donor graft and recipient regarding short-term outcomes after RAPID in the setting of portal vs. no portal hypertension? • Standardization of the technique
Utz Settmacher (Germany)
Oct 18 (Wed) 16:20-16:40
Coffee Break
All
Oct 18 (Wed) 16:40-18:10
RAPID Consensus
Danish Model for ISLS Consensus on Recommendations for RAPID Liver Transplant
Main Room
16:40-17:10
What is the optimal modification of hepatic hemodynamics (portal pressures and flows) to improve short-term outcomes of the recipient after RAPID? • How and when should the flow be measured?
Cristiano Quintini (United Arabic Emirates)
17:10-17:40
When is the optimal timing of the native liver removal to ensure improved short-term outcomes of the recipient in the setting of portal vs. no portal hypertension?
Roberto Troisi (Italy)
17:40-18:10
What is the optimal small for size graft detection and management? • Regeneration, the effect of the remnant liver on the graft. • How should the liver function be measured? • Interstage graft monitoring: Clinical and radiological
Yuji Soejima (Japan)
Oct 19 (Thu) 08:00-09:00
Free Papers 1
Minimally Invasive Surgery
Main Room
Moderator(s)
Dong-Sik Kim (Korea)
Albert Chan (Hong Kong)
08:00-08:10
Donor Safety and Risk Factors of Pure Laparoscopic Living Donor Right Hepatectomy: A Korean Multicenter Study
Sang-Hoon Kim (Hong Kong)
08:10-08:20
Moving Towards a Robotic Preferred Approach in an MIS HPB Surgery Division
Juan Pablo Rocca (United States)
08:20-08:30
A North American center's performance compared to the global benchmark set for laparoscopic liver resections
Woo Jin Choi (Canada)
08:30-08:40
Effectiveness of Minimally Invasive Hepatectomy in Patients with Early or Intermediate-stage Hepatocellular Carcinoma: A Multi-institutional Cohort Study
RUEYSHYANG SOONG (Taiwan)
08:40-08:50
Robotic donor hepatectomy: towards becoming standard of care in living donor liver transplantation
Kamal Yadav (India)
08:50-09:00
Indication model for laparoscopic repeat liver resection in the era of artificial intelligence: Machine learning prediction of surgical indication
Eunjin Lee (Republic of Korea)
Oct 19 (Thu) 09:00-10:30
Live Demonstration 1
Robotic HB Surgery
Main Room
Moderator(s)
Kwan Woo Kim (Korea)
Dieter Broering (Saudi Arabia)
Karim J. Halazun (USA)
Avi Soin (India)
Live Demonstration Robotic Liver Resection from Modena
Fabrizio Di Benedetto (Italy)
How to build the program for robotic liver resection?
Hugo Pinto Marques (Portugal)
Full robotic approaches for HCC
Stefano Di Sandro (Italy)
Robotic liver resection for intrahepatic cholangiocarcinoma with lymph node dissection
Gi Hong Choi (Korea)
Tips and tricks of robotic liver donor operation
Dieter Broering (Saudi Arabia)
Oct 19 (Thu) 10:30-10:50
Coffee Break
All
Oct 19 (Thu) 10:50-12:20
Live Demonstration 2
Laparoscopic HB Surgery
Main Room
Moderator(s)
Marieke T. de Boer (Netherlands)
Alfred Kow (Singapore)
Ki-Hun Kim (Korea)
Olivier Soubrane (France)
Live Demonstration Laparoscopic Liver Resection from Paris
Olivier Scatton (France)
Cholangiocarcinoma: current status of laparoscopic resection
Francois Cauchy (France)
Hepatocellular carcinoma: current status of laparoscopic resection
Albert Chan (Hong Kong)
Living donor liver donation: current status of laparoscopic surgery
Ki-Hun Kim (Korea)
3D-laparoscopic versus robotic hepatectomy
Claire Goumard (France)
Oct 19 (Thu) 12:30-12:50
Special Lecture 1
Main Room
Quality and outcome in HPB surgery
Pierre-Alain Clavien (Switzerland)
Oct 19 (Thu) 12:50-13:30
Luncheon Symposium 1
Blood flow and liver volume in liver surgery and transplantation
Main Room
Moderator(s)
Deniz Balci (Turkiye)
Dimitri Raptis (United Kingdom)
12:50-13:10
Importance of arterial blood flow in liver transplant recipients
Cristiano Quintini (United Arabic Emirates)
13:10-13:30
Developer’s perspective of computer-assisted 3D liver imaging and simulation
Cumhur Ceken (Turkiye)
Oct 19 (Thu) 13:30-15:20
Workshop 1
Machine Liver Perfusion Workshop (Live Demonstration from the Perfusion Lab)
Main Room
Oct 19 (Thu) 13:30-15:20
Workshop 2
Hands on intraoperative ultrasound PART 1: Get into the IOUS-Surgery
Side Room
Moderator(s)
Course Director: Guido Torzilli (Italy)
13:00-13:20
Basic of Ultrasound Technology
Soleen Stocker (Switzerland)
13:20-13:40
IOUS Liver Anatomy & Exploration
Ender Dulundu (Turkiye)
13:40-14:00
IOUS identification and details of liver lesions
Michelle de Oliveira (Switzerland)
14:00-14:20
Contrast enhanced & color flow IOUS
Matteo Donadon (Italy)
14:20-14:40
Laparoscopic and robotic IOUS guidance
Fabio Procopio (Italy)
14:40-15:20
IOUS-guidance & cluster approach in liver surgery
Guido Torzilli (Italy)
Oct 19 (Thu) 15:20-15:40
Coffee Break
All
Oct 19 (Thu) 15:40-17:10
Workshop 1
Machine Liver Perfusion Workshop (Liver Quality Check Before Use – Current Evidence and Pitfalls)
Main Room
Moderator(s)
Philipp Dutkowski (Switzerland)
Markus Selzner (Canada)
15:40-15:55
Viability assessment during normothermic regional perfusion (NRP)
Jeroen de Jonge (Netherlands)
15:55-16:10
Viability assessment during normothermic machine perfusion (NMP)
David Nasralla (United Kingdom)
16:10-16:25
Viability assessment during DHOPE and NMP
Damiano Patrono (Italy)
16:25-16:40
Viability assessment during DHOPE/COR/NMP
Otto van Leeuven (Netherlands)
16:40-16:55
Viability assessment during HOPE alone?
Philipp Dutkowski (Switzerland)
16:55-17:10
Discussion
Oct 19 (Thu) 15:40-17:10
Workshop 2
Hands on intraoperative ultrasound PART 2: Lab Session - Stations with Phantom Models
Side Room
Moderator(s)
Ender Dulundu (Turkiye)
Guido Torzilli (Italy)
Tutor: Ho Joong Choi (Korea)
Matteo Donadon (Italy)
Fabio Procopio (Italy)
Oct 19 (Thu) 17:10-19:00
Opening Ceremony
Welcome Address
Main Room
17:10-17:25
Welcome Address from ISLS President
Jan Lerut (ISLS President)
17:25-17:40
Welcome Address from ISLS 2023 Congress President
Henrik Petrowsky (ISLS 2023 Congress President)
Oct 20 (Fri) 07:30-08:30
Free Papers 2
Liver Transplantation
Main Room
Moderator(s)
Dong Hwan Jung (Korea)
Nicholas Goldaracena (USA)
07:30-07:40
Outcomes of Combined Liver-Lung Transplantation: A Decade-Long Experience
Chase Wehrle (United States)
07:40-07:50
Survival benefit of ABO incompatible living-donor liver transplantation in patients with a high Model for End-stage Liver Disease score over 30
Deok-Gie Kim (Republic of Korea)
07:50-08:00
Achieving 400 living donor liver transplantations annually during the COVID-19 pandemic: A Single Center Experience
Sung-Min Kim (Republic of Korea)
08:00-08:10
Transplantation After Ex-situ Normothermic Preservation Using Institutional-Developed Device On Livers From Donors After Circulatory Death
Chase Wehrle (United States)
08:10-08:20
Donor Complications Among 1126 Living Donor Liver Transplantation
Tongu Utku YILMAZ (Turkiye)
08:20-08:30
Preliminary single-center experience in liver transplantation using the RAPID technique: technical improvement and lessons learned from initial cases.
Laurent Coubeau (Belgium)
Oct 20 (Fri) 07:30-08:30
Free Papers 3
Liver General
Side Room
Moderator(s)
Alejandro Serrablo (Spain)
Mustafa Kerem (Türkiye)
07:30-07:40
Impact of Endothelial Nitric Oxide Synthase Activation on Accelerated Liver Regeneration in a Rat ALPPS Model
Hitoshi Masuo (Japan)
07:40-07:50
Identifying stage-specific activation of molecular pathways and immunoprofile in hepatocellular carcinoma (HCC) using RNA sequencing and immune deconvolution
Bonnie Chow (United States)
07:50-08:00
Impact of direct-acting antiviral therapy in hepatitis C virus-related hepatocellular carcinoma after hepatectomy: A multicenter international study
Woo Jin Choi (Canada)
08:00-08:10
Promising outcome of portal vein arterialization as a salvage method in advanced HPB surgery
Ali Majlesara (Germany)
08:10-08:20
Recurrence risk after parenchymal R1 liver resection for colorectal liver metastasis: is it a local matter
Thomas Baron (France)
08:20-08:30
A Hepatocellular Cancer Patient Derived Organoid Xenograft Model To Investigate The Impact Of Liver Legeneration On Tumor Growth
Philipp Sedlaczek (Switzerland)
Oct 20 (Fri) 08:30-09:00
Welcome Address
Main Room
Moderator(s)
Jan Lerut (ISLS President)
Henrik Petrowsky (ISLS 2023 Congress President)
Oct 20 (Fri) 09:00-10:30
Session 1:
ISLS Study Group Reports
Main Room
Moderator(s)
Deniz Balci (Türkiye)
Henrik Petrowsky (Switzerland)
09:00-09:09
Competing impact of tumor biology and tumor burden/extent of resection on outcome after hepatectomy for colorectal liver metastases
Ruslan Alikhanov (Russia)
Henrik Petrowsky (Switzerland)
09:09-09:18
Curative resection following neo-adjuvant therapy in patients with high risk HCC features
Parissa Tabrizian (USA)
Albert Chan (China)
09:18-09:27
Liver resection for synchronous metastasis from pancreatıc cancer
Orlando Torres (Brazil)
Fabrizio Di Benedetto (Italy)
09:27-09:36
Results of laparoscopic extended cholecystectomy in gallbaldder cancer
Alfred Kow (Singapore)
09:36-09:45
Risk factor analysis of HCC recurrence after living donor liver transplantation
Dong Jin Joo (Korea)
Gonzalo Sapisochin (Canada)
09:45-09:54
Impact of complex bilio-vascular donor anatomy on donor and recipient morbidity in adult LDLT
Prashant Bhangui (India)
09:54-10:03
Study development of futility index in deceased donor liver transplantation
Dong-Sik Kim (Korea)
Karim J. Halazun (USA)
10:03-10:12
Early allograft dysfunction in liver transplantation: Is it valid internationally?
Burcin Ekser (USA)
Cristiano Quintini (United Arabic Emirates)
10:12-10:21
Surgical and oncological outcomes of laparoscopic versus open liver resection for intrahepatic CCA
Jong Man Kim (Korea)
Silvio Nadalin (Germany)
10:21-10:30
Discussion
Oct 20 (Fri) 10:30-10:50
Coffee Break
All
Oct 20 (Fri) 10:50-11:50
Session 2:
Regenerative Liver Surgery
Main Room
Moderator(s)
Roberto Troisi (Italy)
Pal-Dag Line (Norway)
10:50-11:05
Liver regeneration from bench to bedside
Henrik Petrowsky (Switzerland)
11:05-11:20
Liver resection after liver venous deprivation
Fabrizio Panaro (France)
11:20-11:35
The magic of ALPPS for rapid liver regeneration
Karl Oldhafer (Germany)
11:35-11:50
How to tweak small liver graft regeneration RAPID(ly)
Deniz Balci (Türkiye)
Oct 20 (Fri) 11:50-12:20
Session 2 Debate:
ALPPS or biembolization – what is better?
Main Room
Moderator(s)
Rafael Diaz-Nieto (United Kingdom)
Stefano Di Sandro (Italy)
11:50-12:00
Pro Double embolization
Mickaël Lesurtel (France)
12:00-12:10
Pro ALPPS
Eduardo Fernandes (Brazil)
12:10-12:20
Discussion
Oct 20 (Fri) 12:30-13:30
Luncheon Symposium 2
Immunotherapy and Liver Surgery
Main Room
Moderator(s)
Myron Schwartz (USA)
Yuman Fong (USA)
12:30-12:50
The rise of transplant oncology
Gonzalo Sapisochin (Canada)
12:50-13:05
Immunotherapy and liver surgery for hepatocellular carcinoma
Myron Schwartz (USA)
13:05-13:20
Adjuvant immunotherapy and resection for hepatocellular carcinoma: IMBRAVE 050
Adam Yopp (USA)
13:20-13:30
Panel Discussion
Parissa Tabrizian (USA)
Oct 20 (Fri) 12:30-13:30
Poster Presentation 1
Screen 1 (Liver Transplantation)
Gallery, Level 02
Moderator(s)
Michael Linecker (Germany)
Michelle de Oliveira (Switzerland)
12:30-12:36
Diagnostic Accuracy of LiverVision Software: A Study on Semi-Automated Liver Volumetry in Living Donor Liver Transplantation
Deniz Balci (Turkiye)
12:36-12:42
Utilisation of Novel Definition and Grading System for Small for Size Syndrome: Frequencies and Relations with Transplant Outcomes in a Right Lobe LDLT Cohort
Elvan Onur Kirimler (Turkiye)
12:42-12:48
3D-Reconstruction and Heterotopic Implantation of Reduced Size Monosegment or Left Lateral Segment and left lobe Grafts in children:A New Technique in Pediatric Living Donor Liver Transplantation to Overcome Large-For-Size-Syndrome
Meltem Bingol Kologlu (Turkiye)
12:48-12:54
Risk factors associated with surgical morbidities of laparoscopic living liver donors
Eunjin Lee (Republic of Korea)
12:54-13:00
Risk assessment in Liver Transplantation for Hepatocellular Carcinoma: Long-Term Follow-Up of a Two-Center Experience
Chase Wehrle (United States)
13:00-13:06
Left at Right Heterotopic implantation of left liver graft in living donor liver transplantation
Jaryung Han (Republic of Korea)
13:06-13:12
Intracardiac Thrombosis During Liver Transplantation: A Single Center Analysis
Luca Del Prete (Italy)
13:12-13:18
Early Hepatic Artery Thrombosis Treatments and Outcomes: Aorto-hepatic Arterial Conduit Interposition or Revision of the Anastomosis
Alireza Shamsaeefar (Iran)
13:18-13:24
Usefulness of branched-chain amino acids in restoration of liver function after donor right hepatectomy.
Gun Hyung Na (Republic of Korea)
13:24-13:30
Oct 20 (Fri) 12:30-13:30
Poster Presentation 1
Screen 2 (Minimally Invasive Surgery & Liver General)
Gallery, Level 02
Moderator(s)
Paolo Magistri (Italy)
Varvara Kirschner (USA)
12:30-12:36
Efficacy of Technical Modifications to the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure: A Systematic Review and Meta-Analysis
Elias Khajeh (Germany)
12:36-12:42
Image-Based Artificial Intelligence Effectiveness in Predicting Colorectal Liver Metastatic Tumor Growth Features and Patient Outcomes
Mingqian Han (China)
12:42-12:48
Clinical Outcome Of Laparoscopic Versus Open Approach In Right Posterior Sectionectomy: The HKU Experience
Allan Hoi Kin Lam (Hong Kong)
12:48-12:54
Bi-centric comparison of full robotic versus open ALPPS
Cristiano Guidetti (Italy)
12:54-13:00
Anatomic versus non-anatomic liver resection for hepatocellular carcinoma - impact of cirrhosis
Noa Aegerter (Switzerland)
13:00-13:06
Comparison of Open versus Laparoscopic Approaches in Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation
Jinju Kim (Republic of Korea)
13:06-13:12
Pure Abdominal Approach in Laparoscopic Parenchymal-sparing Liver Resections of the Posterosuperior Region Our Experience
Ivelin Takorov (Bulgaria)
13:12-13:18
Pure Laparoscopic Living Donor Hepatectomy and Conventional Open Procedure: A Retrospective Study in Vietnam
Hieu Le Trung (Vietnam)
13:18-13:24
ASSOCIATION OF LAPAROSCOPIC SURGERY WITH IMPROVED PERIOPERATIVE AND SURVIVAL OUTCOMES IN PATIENTS WITH RESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Daniel Aliseda (Spain)
Oct 20 (Fri) 12:30-13:30
Poster Presentation 1
Screen 3 (Pancreatic, Biliary, Basic and Others)
Gallery, Level 02
Moderator(s)
Gokhan Kabacam (Türkiye)
Francois Cauchy (France)
12:30-12:36
Use of supervised machine learning algorithms in predicting postoperative mortality in gastrointestinal and HPB surgeries
Bhavin Vasavada (India)
12:36-12:42
Retrospective application and validation of Tokyo 18 guidelines for diagnosis and stratification of acute cholangitis in Qatar
Mohamed Ghali (Qatar)
12:42-12:48
Tumor-Associated Macrophage (TAM) in Intrahepatic Cholangiocarcinoma (ICC) as Prognostic and Therapeutic Target
Varvara Kirchner (United States)
12:48-12:54
Short- and long-term outcome after surgical management of common bile duct stones
Philipp Sedlaczek (Switzerland)
12:54-13:00
Robotic Vs Open Pancreatoduodenectomy for Periampullary Neoplasm: A Retrospective Analysis of Peri-operative and Oncologic Outcomes
Vaibhav Kumar Varshney (India)
13:00-13:06
NEW TUNNEL TECHNIQUE IN LAPAROSCOPIC-CHOLANGIOSCOPIC COOPERATIVE SURGERY FOR HEPATOLITHIASIS COMBINED WITH DILATED COMMON BILE DUCT
Hieu Le Trung (Vietnam)
13:06-13:12
Difficult robotic pancreaticoduodenectomy: should we perform it by open approach
Carolina Gonzalez-Abos (Spain)
13:12-13:18
Personalised surgical site infection prophylaxis according to bile cultures in patients undergoing pancreaticoduodenectomy for periampullary tumours
Roman Kursenko (Russia)
13:18-13:24
Hepatobiliary And Pancreatic Ascariasis-Experience From A Tertiary Care Hospital In North East India
Ranendra Hajong (India)
13:24-13:30
Laparoscopic Cholecystectomy in Elderly Patients with Acute Cholecystitis
Dmytro Osadchuk (Ukraine)
Oct 20 (Fri) 13:30-13:50
Special Lecture 2
Main Room
Moderator(s)
Jan Lerut (Belgium)
Immune tolerance in liver transplantation: Is immunosuppression-free management possible?
Sandy Feng (USA)
Oct 20 (Fri) 13:50-14:50
Session 3:
Intrahepatic and Perihilar Cholangiocarcinoma
Main Room
Moderator(s)
Eric Vibert (France)
Umberto Cillo (Italy)
13:50-14:05
State of the art liver resection for perihilar cholangiocarcinoma
Hauke Lang (Germany)
14:05-14:20
Is ALPPS justıfied today for intra- and perihilar cholangiocarcinoma
Silvio Nadalin (Germany)
14:20-14:35
Robotic surgery for cholangiocarcinoma
Fabrizio Di Benedetto (Italy)
14:35-14:50
Effectiveness of neo-adjuvant conversion strategies forintrahepatic cholangiocarcinoma: chemotherapy, hepatuc arterial infusion pump and transarterial radio-embolisation
Sean Cleary (USA)
Oct 20 (Fri) 14:50-15:20
Session 3 Debate:
Resection versus transplantation for Bismuth IV perihilar cholangiocarcinoma
Main Room
Moderator(s)
Utz Settmacher (Germany)
Philipp Dutkowski (Switzerland)
14:50-15:00
Pro Resection
Roberto Troisi (Italy)
15:00-15:10
Pro Transplantation
Shimul Shah (USA)
15:10-15:20
Discussion
Oct 20 (Fri) 15:20-15:40
Coffee Break
All
Oct 20 (Fri) 15:40-17:10
Session 4:
ISLS meets it’s partners: State-of-the-art lectures
Main Room
Moderator(s)
Jan Lerut (Belgium)
Nazia Selzner (Canada)
Yaman Tokat (Türkiye)
15:40-15:55
ISLS meets IHPBA: Current standards of palliative resection for colorectal liver metastases
Rene Adam (France)
15:55-16:10
ISLS meets Asian-Pacific HPBA: Current standards in the management of pancreatic cystic lesions
Shailesh Shrikhande (India)
16:10-16:25
ISLS meets Americas HPBA: Current standards of hepatic artery infusion chemotherapy before and after liver surgery
Majella Doyle (USA)
16:25-16:40
ISLS meets IASGO: Current standards of liver surgery for colerectal liver metastasis
Ender Dulundu (Türkiye)
16:40-16:55
ISLS meets ILTS: Current standards of liver transplantation for intrahepatic cholangiocarcionoma
R. Mark Ghobrial (USA)
16:55-17:10
Panel Discussion: Collaborations between societies in 2023: chances and obstacles
Oct 20 (Fri) 17:10-18:00
Video Session 1: Five Videos
Main Room
Moderator(s)
Massimo Malago (United Kingdom)
Ruslan Alikhanov (Russia)
17:10-17:20
Robotic Liver Transplant of a Whole Organ Graft from a Deceased Donor
Majella Doyle (USA)
17:20-17:30
RAPID-type auxiliary liver transplantation in non cirrhotic setting : First surgical step (video).
Laurent Coubeau (Belgium)
17:30-17:40
Combined Pancreatoduodenectomy and Living Donor Liver Transplantation for Metastatic Pancreas Head Neuroendocrine Tumor
Eduardo de Souza Martins Fernandes (Brazil)
17:40-17:50
Dual Liver - Living Donors Liver Transplanation
Luca Perin (Italy)
17:50-18:00
Aggressive surgical approach for acute massive upper gastrointestinal bleeding in a non-cirrhotic patient with diffuse portal vein thrombosis and left-sided portal hypertension
Lucas Mc Cormack (Argentina)
Oct 20 (Fri) 19:00-21:00
Gala Dinner
*Ticket Only Event
All
Oct 21 (Sat) 07:30-08:30
Free Papers 4
Pancreatic Disease
Main Room
Moderator(s)
Ki Byung Song (Korea)
Orlando Torres (Brazil)
07:30-07:40
Neoadjuvant Treatment improves Long Term Survival in Resectable and Borderline Resectable Pancreatic Cancer: A Patient-Level Meta-Analysis from Randomized Controlled Trials
Daniel Aliseda (Spain)
07:40-07:50
Robotic vs Open Pancreaticoduodenectomy: Analysis of Short-term Outcomes at the University of Modena.
Cristiano Guidetti (Italy)
07:50-08:00
Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis
Qian Yan (China)
08:00-08:10
Perioperative Platelet Count Ratio Predicts Long-term Survival after Left Pancreatectomy and Splenectomy for Pancreatic Adenocarcinoma
Niv Pencovich (Israel)
08:10-08:20
Immune Disbalance In Peripheral Blood Mononuclear Cells of Pancreatic Cancer Patients is Related to Low Expression of AHR
Zilvinas Dambrauskas (Lithuania)
08:20-08:30
Prognostic significance of insulin resistance in pancreatic cancer patients with diabetes mellitus base on glucose and lipid metabolic index
Hailiang Wang (China)
Oct 21 (Sat) 07:30-08:30
Free Papers 5
Biliary Disease
Side Room
Moderator(s)
Shintaro Yagi (Japan)
07:30-07:40
Call to Improve the Quality of Prediction Tools for Intrahepatic Cholangiocarcinoma Resection: A Critical Appraisal, Systematic Review, and External Validation Study
Woo Jin Choi (Canada)
07:40-07:50
Impact of tumour laterality on peri-operative and survival outcomes in gallbladder cancer: Need to differentiate medial and lateral located cancers
Swapnil Patel (India)
07:50-08:00
Safety and Efficacy of Major Hepatopancreatoduodenectomy for Perihilar Cholangiocarcinoma
Noriyuki Kitagawa (Japan)
08:00-08:10
Robotic approach for perihilar cholangiocarcinoma: from Bismuth 1 to vascular resection
Paolo Magistri (Italy)
08:10-08:20
Our Novel Clip-Clamp-Cut (Triple C) Technique Of Bloodless Hepatic Duct Division During Robotic Donor Hepatectomy
Kamal Yadav (India)
Oct 21 (Sat) 08:30-09:30
Session 5:
Pancreas
Main Room
Moderator(s)
Eduardo Fernandes (Brazil)
Ugo Boggi (Italy)
08:30-08:45
Vascular resections and outcome in borderline resectable pancreatic cancer
Beat Müller (Switzerland)
08:45-09:00
Resection and outcomes of oligometastatic pancreas cancer
Thilo Hackert (Germany)
09:00-09:15
Prospective global snap shot study of pancreactic surgery
Dimitri Raptis (United Kingdom)
09:15-09:30
Should we do robotic pancreas transplants?
Jose Oberholzer (Switzerland)
Oct 21 (Sat) 09:30-10:00
Session 5 Debate:
Resectable pancreatic cancer: Neoadjuvant treatment upfront surgery
Main Room
Moderator(s)
Lucas McCormack (Argentina)
Hugo Pinto Marques (Portugal)
09:30-09:40
Pro Neo-adjuvant treatment
Sébastien Gaujoux (France)
09:40-09:50
Pro Upfront surgery
Christoph Michalski (Germany)
09:50-10:00
Discussion
Oct 21 (Sat) 10:00-10:30
General Assembly
Main Room
Oct 21 (Sat) 10:30-10:50
Coffee Break
All
Oct 21 (Sat) 10:50-11:10
Special Lecture 3
Main Room
Moderator(s)
Myron Schwartz (USA)
What does it take to be a true surgeon scientist?
Yuman Fong (USA)
Oct 21 (Sat) 11:10-12:20
Best ISLS Papers
Main Room
Moderator(s)
Jan Lerut (Belgium)
Henrik Petrowsky (Switzerland)
Ki-Hun Kim (Korea)
11:10-11:20
Surgical outcome of HCC with portal vein tumor thrombosis on the basis of risk scoring; multi-center study in South Korea
Koo Jeong Kang (Republic of Korea)
11:20-11:30
Is patient selection important in improving the rates of 2nd stage hepatectomy following venous deprivation (PVE or DVE)
Bobby VM Dasari (United Kingdom)
11:30-11:40
Analysis of Open, Laparoscopic, and Robotic Living Donor Liver Transplant Outcomes: A Single Center Prospective Registry Study of 1607 Cases
Dimitri Aristotle Raptis (Saudi Arabia)
11:40-11:50
Hepatic Arterial Flow Graft Weight Ratio predicts early allograft dysfunction and small-for-size-syndrome in living donor liver transplantation.
Elvan Onur Kirimker (Turkiye)
11:50-12:00
Textbook outcome in patients with biliary duct injury during cholecystectomy
Christoph Kuemmerli (Switzerland)
12:00-12:10
The Impact of Liver Transplantation Experience on the Complexity and Outcomes of Laparoscopic Liver Resection: A French Nationwide Study
Sophie Laroche (France)
Oct 21 (Sat) 12:30-13:30
Luncheon Symposium 3
Artificial Intelligence
Main Room
Moderator(s)
Alfred Kow (Singapore)
Eric Vibert (France)
12:30-12:42
AI and Image-guided surgery in HPB - Towards precision surgery
Alfred Kow (Singapore)
12:42-12:54
AI in minimally invasive liver surgery: before and during operation
Namkee Oh (Korea)
12:54-13:06
Leveraging 5G, AI and Azure to scale HoloMedicine® in hospitals
Sirko Pelzl (Germany)
13:06-13:18
Use of computer-assisted liver surgery with 3D-printing
Jiri Fronek (Czech Republic)
13:18-13:30
Q&A
Oct 21 (Sat) 12:30-13:30
Poster Presentation 2
Screen 1 (Liver transplantation)
Gallery, Level 02
Moderator(s)
Young-In Yoon (Korea)
Prashant Bhangui (India)
12:30-12:36
Multivariable linear model for predicting graft weight based on 3-dimensional volumetry in regards of body weight change of living liver donor.
Eunjin Lee (Republic of Korea)
12:36-12:42
Donor Safety of Remnant Liver Volumes of Less Than 30% in Living Donor Liver Transplantation: A Systematic Review and Meta-Analysis
Sang-Hoon Kim (Republic of Korea)
12:42-12:48
Reverse Portal Flow Modulation can save a failing graft after 1st stage of Rapid Procedure
Emre Aray (Turkiye)
12:48-12:54
Comparative Outcomes of Living Donor Liver Transplantation in Elderly Recipients: A Study on Short-term Morbidity and Long-term Survival in 1,018 cases
Dimitri Aristotle Raptis (Saudi Arabia)
12:54-13:00
Comparing the outcomes of deceased and living donor liver re-transplantation in adult patients
Kamil Yalcin Polat (Turkiye)
13:00-13:06
Emergency total hepatectomy awaiting urgent liver transplantation - A rare life-saving rescue procedure in selected patients
Philipp Dominique Kron (Switzerland)
13:06-13:12
Outcomes of Adult Living Donor Liver Transplantation for Acute Liver Failure; A 15-Year Experience in a Single Center
Geunhyeok Yang (Republic of Korea)
13:12-13:18
Graft to Splenic Volume Ratio (GSVR) as a Predictor of Early Allograft Dysfunction in Low Graft by Recipient Weight Ratio (GRWR) patients undergoing Living Donor Liver Transplantation: A Retrospective Analysis
Nikhitha Shetty (India)
Oct 21 (Sat) 12:30-13:30
Poster Presentation 2
Screen 2 (Minimally Invasive Surgery & Liver General)
Gallery, Level 02
Moderator(s)
Nicholas Goldaracena (USA)
Parissa Tabrizian (USA)
12:30-12:36
Associating liver partition and portal vein ligation for staged hepatectomy: Laparoscopic versus open approach and its impact on on rate of future remnant hypertrophy
Kin Pan Au (Hong Kong)
12:36-12:42
Clinical Evidence for Soluble ST2 as a Predictor of Postoperative Liver Dysfunction
Jing Wu (China)
12:42-12:48
Extreme Liver Resection Techniques and Outcomes In a High-Volume Center
Ron Pery (Israel)
12:48-12:54
Liver resection involving retrohepatic IVC
Vassil Mihaylov (Bulgaria)
12:54-13:00
Artificial Intelligence for Identification of Focal Lesions in Intraoperative Liver Ultrasonography
Niv Pencovich (Israel)
13:00-13:06
Comparison of surgical and long term outcomes after hepatectomy in patients with NAFLD-HCC versus HBV-HCC: A multicenter study
Na Reum Kim (Republic of Korea)
13:06-13:12
The method of using robotic Harmonic ultrasonic shear for parenchymal transection in Robotic Right hepatectomy
Eun Jeong Jang (Republic of Korea)
13:12-13:18
Lessons Learned from Laparoscopic Liver Surgery: A Retrospective single-centre Study of 270 Cases from Ukrainian high-volume hepatobiliary centre
Denys Fedorov (Ukraine)
13:18-13:24
The learning curve of pure laparoscopic liver resection based on previous experience
Hwui-Dong Cho (Republic of Korea)
Cancelled
13:24-13:30
Perioperative Use of Statins and Metformin but not Aspirin Reduces Recurrence after Curative Liver Resection in Patients with Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Elias Khajeh (Germany)
Oct 21 (Sat) 12:30-13:30
Poster Presentation 2
Screen 3 (Pancreatic, Biliary, Basic and Others)
Gallery, Level 02
Moderator(s)
Lucas McCormack (Argentina)
Shintaro Yagi (Japan)
12:30-12:36
Prognostic and genetic characteristics of cholangiocarcinoma based on microscopic classification
Keun Soo Ahn (Republic of Korea)
12:36-12:42
A Model to Predict Significant Macrosteatosis in Hepatic Graft
Ahmed Swelam (Egypt)
12:42-12:48
Learning and experience in hepatic resection of 158 Cholangiocarcinoma patients; Young surgeon perspective.
Poowanai Sarkhampee (Thailand)
12:48-12:54
Inferior-Medial Approach for Laparoscopic Splenic Vessel-Preserving Distal Pancreatectomy : A Single Surgeons Experience
Joodong Kim (Republic of Korea)
12:54-13:00
Timing for a surgically safe and oncologically prompt pancreatoduodenectomy after preoperative biliary drainage in patients with bile duct cancer
Okjoo Lee (Republic of Korea)
13:00-13:06
Significance of Minimally Invasive Distal pancreatectomy using Retroperitoneal laparoscopic approach for left-sided pancreatic cancer
Taku Ilda (Japan)
Oct 21 (Sat) 13:30-14:30
Session 6:
Colorectal Liver Metastases (CRLM)
Main Room
Moderator(s)
Marieke T. de Boer (Netherlands)
Christian Toso (Switzerland)
13:30-13:45
Laparoscopic two stage hepatectomy for CRLM
Olivier Scatton (France)
13:45-14:00
ALPPS for CRLM
Per Sandström (Sweden)
14:00-14:15
Resection for colorectal liver metastases: How far can we go?
Alejandro Serrablo (Spain)
14:15-14:30
Refined transplantation criteria of CRLM
Pal-Dag Line (Norway)
Oct 21 (Sat) 14:30-15:00
Session 6 Debate:
Resect transplantable patients or transplant resectable patients with CRLM?
Main Room
Moderator(s)
Krishna Menon (United Kingdom)
Karl Oldhafer (Germany)
14:30-14:40
Pro Resection
Daniel Azoulay (France)
14:40-14:50
Pro Transplantation
Abhinav Humar (USA)
14:50-15:00
Discussion
Oct 21 (Sat) 15:00-15:20
Special Lecture 4
Main Room
Moderator(s)
Mark Ghobrial (USA)
Advancing the field of living donor liver transplantation
Mohamed Rela (India)
Oct 21 (Sat) 15:20-15:40
Coffee Break
All
Oct 21 (Sat) 15:40-16:40
Session 7:
Hepatocellular Carcinoma
Main Room
Moderator(s)
Jai Young Cho (Korea)
Parissa Tabrizian (France)
15:40-15:55
Resectabiity of BCLC B-C patients
Koo Jeong Kang (Korea)
15:55-16:10
Minimally-invasive liver resection
Krishna Menon (United Kingdom)
16:10-16:25
Downstaging of BCLC-C patients for transplantation
Prashant Bhangui (India)
16:25-16:40
Portal vein tumor invasion: resection vs. transplantation
Christian Toso (Switzerland)
Oct 21 (Sat) 16:40-17:10
Session 7 Debate:
Resectable hepatocellular carcinoma and portal hypertension: resection or transplantation
Main Room
Moderator(s)
Akin Tekin (USA)
16:40-16:50
Pro Resection
Shintaro Yagi (Japan)
16:50-17:00
Pro Transplantation
Karim J. Halazun (USA)
17:00-17:10
Discussion
Oct 21 (Sat) 17:10-18:00
Video Session 2: Five Videos
Main Room
Moderator(s)
Kaan Karayalcin (Türkiye)
Chul-Soo Ahn (Korea)
17:10-17:20
Pure laparoscopic donor right hepatectomy with the type III portal vein variation
Hwui-Dong Cho (Republic of Korea)
Cancelled
17:20-17:30
Laparoscopic Limited Anatomical Liver Resection Using Transfissureal Glissonean Pedicle
Joodong Kim (Republic of Korea)
17:30-17:40
Laparoscopic anatomical resection of segment 4b and 8 using the caudal view, with skeletonization of bile duct bifurcation and hepatic veins using the CUSA clarity dissector
David Henault (Canada)
17:40-17:50
Laparoscopic Associating Liver Partition and Portal vein Ligation for Staged hepatectomy for Hepatocellular Carcinoma
Kin Pan Au (Hong Kong)
Oct 21 (Sat) 17:10-18:00
Video Session 3: Five Videos
Side Room
Moderator(s)
Michelle de Oliveira (Switzerland)
17:10-17:20
Right trisectionectomy with hilar resection with PV resection and IVC resection for Cholangiocarcinoma; Using pure electrocautery technique.
Poowanai Sarkhampee (Thailand)
17:20-17:30
Robotic Radical Cholecystectomy and Extrahepatic Bile Duct Excision with Roux-en-Y Hepaticojejunostomy
Vaibhav Kumar Varshney (India)
17:30-17:40
Robotic portal vein resection and reconstruction for Klatskin 3b tumor.
Cristiano Guidetti (Italy)
Oct 21 (Sat) 18:00-18:20
Closing Remarks
Main Room
Henrik Petrowsky (ISLS 2023 Congress President)